These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 336309)

  • 1. Selected and spontaneous variants of Serratia marcescens with combined resistance against chloramphenicol, nalidixic acid, and trimethoprim.
    Traub WH; Kleber I
    Chemotherapy; 1977; 23(6):436-51. PubMed ID: 336309
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
    Verbist L; Spaepen J; Vandepitte J
    Chemotherapy; 1976; 22(1):43-54. PubMed ID: 767065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nalidixic acid, rifampicin and chloramphenicol on the mitomycin C--induced synthesis of a bacteriocin of Serratia marcescens.
    Eichenlaub R; Winkler U
    Biochem Biophys Res Commun; 1974 Jul; 59(1):133-9. PubMed ID: 4601812
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutants of Klebsiella pneumoniae resistant to several antibiotics.
    Smith HW
    Nature; 1976 Jan; 259(5541):307-8. PubMed ID: 765837
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.
    Gutmann L; Williamson R; Moreau N; Kitzis MD; Collatz E; Acar JF; Goldstein FW
    J Infect Dis; 1985 Mar; 151(3):501-7. PubMed ID: 2982966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of nalidixic acid and mitomycin C on growth and biosynthesis of extracellular proteins by Serratia marcescens].
    Iusupova DV; Sokolova RB; Petukhova EV
    Antibiot Khimioter; 1993; 38(8-9):16-21. PubMed ID: 8037570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
    Berlanga M; Viñas M
    J Antimicrob Chemother; 2000 Aug; 46(2):279-82. PubMed ID: 10933653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity studies on Serratia strains from clinical specimens.
    von Graevenitz A
    Chemotherapy; 1967; 12(4):215-25. PubMed ID: 4863818
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nalidixic acid susceptibility testing of clinical isolates of Serratia marcescens.
    Jollick JD; Schervish-Swierkosz EM; Brown WJ
    Antimicrob Agents Chemother; 1973 Nov; 4(5):532-7. PubMed ID: 4598848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of group A bacteriocins of Serratia marcescens by nalidixic acid.
    Traub WH; Kleber I; Schaber I
    Nat New Biol; 1973 Oct; 245(144):144-5. PubMed ID: 4582895
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a nosocomially significant, multiple drug-resistant strain of Serratia marcescens.
    Traub WH; Kleber I; Pühler A; Burkardt HJ
    Chemotherapy; 1976; 22(5):297-312. PubMed ID: 181215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The susceptibility of Serratia marcescens to sulfamethoxazole, trimethoprim, and trimethoprim-sulfamethoxazole.
    Adeniyi-Jones C; Neilly S; Roberts RS; Kaufmann NR
    J Infect Dis; 1973 Nov; 128():Suppl:534-42 p. PubMed ID: 4585956
    [No Abstract]   [Full Text] [Related]  

  • 18. Killing of Serratia marcescens biofilms with chloramphenicol.
    Ray C; Shenoy AT; Orihuela CJ; González-Juarbe N
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):19. PubMed ID: 28356113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of chloramphenicol resistance in Serratia marcescens recently isolated from a clinical material (author's transl)].
    Terao M; Morishita H; Miyamura S
    Nihon Saikingaku Zasshi; 1981 May; 36(3):583-9. PubMed ID: 7038193
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.